scholarly journals The Effects of Becoming a Physician on Prescription Drug Use and Mental Health Treatment

2021 ◽  
Author(s):  
D. Mark Anderson ◽  
Ron Diris ◽  
Raymond Montizaan ◽  
Daniel Rees
2021 ◽  
Vol 29 (1-2) ◽  
Author(s):  
Marianne Lindstad ◽  
Svetlana Skurtveit ◽  
Anne Bukten

SAMMENDRAGBakgrunn: Legemiddelbruk i den norske befolkningen er økende. Kunnskap om omfang, hvem brukerne er og bruksmønster er en forutsetning for optimalisering av legemiddelbruk i alle grupper av befolkningen. Samtidig finnes det ingen oppdaterte studier som viser bruk av forskrevne legemidler blant innsatte i Norge. Hensikten med denne studien er derfor å beskrive bruk av forskrevne psykofarmaka blant innsatte i fengsel før og under soning, samt undersøke hvilke faktorer som er assosiert med legemiddelbruk.Material og metode: Datamaterialet er fra «The Norwegian Offender Mental Health and Addiction Study», NorMA-studien, som ble gjennomført i perioden 2013-2014 ved 57 fengselsenheter i Norge. Totalt svarte 1495 innsatte (96 kvinner) på spørreskjema. Vi undersøkte selvrapportert bruk av psykofarmaka knyttet til sovemedisin, beroligende legemidler, antidepressiva, LAR-legemidler, smertestillende legemidler og ADHD- legemidler. Vi brukte logistiske regresjoner for å undersøke sammenhenger mellom ulike bakgrunnsfaktorer og bruk av ulike legemidler under soning.Resultater: Sovemedisin var mest brukt, både før og under soning. Tjue prosent av innsatte brukte sove- medisin daglig under soning. Innsatte brukte mer psykofarmaka enn den generelle befolkningen, med unntak av smertestillende legemidler. Under soning var bruk av de fleste undersøkte psykofarmaka assosiert med betydelige psykiske plager, skadelig rusbruk, å motta økonomiske sosiale ytelser samt å ha hatt en oppvekst preget av rus og psykiske problemer.Konklusjon: Våre funn viser at innsattes psykiske helse og russituasjon bør ha høy prioritet under soning. Det er forventet at innsatte bruker mer forskrevne psykofarmaka enn den generelle befolkningen. At den generelle befolkningen bruker mer smertestillende enn innsatte, bør derfor undersøkes nærmere. Lindstad M, Skurtveit S, Bukten A. Too much or too little medication? A national study of prescribedpsychotropic drugs among inmates in Norwegian prisons. Norsk Epidemiologi 2021; 29 (1-2): 85-95.ENGLISH SUMMARYBackground: Prescription drug use in the Norwegian population is increasing. Knowledge of who the usersareand usage patterns is a prerequisite for optimizing prescription drug use in all groups of the population.There are no updated studies describing prescription drug use among prisoners in Norway. The purpose ofthis study is to describe the use of prescribed psychotropic drugs among inmates in prison before and duringimprisonment and to investigate factors associated with prescription drug use while in prison.Material and method: The study is based on self-reported data from "The Norwegian Offender MentalHealth and Addiction Study" (NorMA) which was conducted in the period 2013-2014 at 57 prison units inNorway. A total of 1495 inmates (96 women) responded to the questionnaire. We investigated self-reporteduse of psychotropic drugs related to: hypnotics, anxiolytics, antidepressants, OMT-medications, pain medicationand ADHD-medications. We used logistic regression models to investigate relationships betweendifferent background factors and the use of prescribed drugs during imprisonment.Results: Hypnotics were most commonly used, both before and during imprisonment. Twenty percent ofinmates had used hypnotics daily during imprisonment. Inmates used more psychotropic drugs than the generalpopulation, with the exception of pain medications. During imprisonment, usage of most psychotropicdrugs imprisonment were associated with symptoms of mental illness, harmful drug use before imprisonment,having received social benefits and to have had an upbringing marked by drug use and mental problems.Conclusion: Our findings show that prisoners' mental health and substance use situation should have a highpriority during imprisonment. It is expected that inmates use more prescribed psychotropic drugs than thegeneral population. The fact that the general population uses more pain medication than inmates shouldtherefore be investigated further. 


2020 ◽  
Vol 4 (1) ◽  
pp. e000674
Author(s):  
Emma Sparks ◽  
Liliane Zorzela ◽  
Candace Necyk ◽  
Baljit Khamba ◽  
Liana Urichuk ◽  
...  

BackgroundPaediatric mental health patients frequently use natural health products (NHP) in addition to prescription medications, but very little is known about adverse events and possible NHP–drug interactions.ObjectiveTo determine: (1) the prevalence of paediatric mental health patients taking prescription medications only, NHP only, both NHP and prescription medications concurrently or neither; (2) which prescription medications and NHP are most commonly used in paediatric mental health populations and (3) adverse events experienced in the last 30 days (serious and non-serious).DesignCross-sectional surveillance study.SettingPaediatric mental health clinics.Population/interventionOn their first clinic visit, paediatric mental health patients were provided with a form inquiring about prescription drug use, NHP use and any undesirable event experienced in the last month.ResultsOf the 536 patients included in this study, 23% (n=120) reported taking only prescription medication(s), 21% (n=109) reported only NHP use, 21% (n=112) reported using both NHP and prescription drugs concurrently, and 36% (n=191) reported using neither. Overall, there were 23 adverse events reported; this represents 6.3%, 2.8%, 10.8% and 0.6% of each population, respectively. The majority of patients who experienced an adverse event reported taking more than one NHP or prescription drug. No serious adverse events were reported.ConclusionNearly half of the paediatric mental health patients in this study were taking NHPs alone or in addition to prescription medications. Active surveillance identified multiple adverse events associated with NHP and prescription drug use; none were serious. Healthcare professionals were encouraged to initiate conversations regarding NHP use.


2011 ◽  
Vol 35 (5) ◽  
pp. 161-163 ◽  
Author(s):  
Nancy M. Petry

SummaryContingency management is a highly effective treatment for substance use and related disorders. However, few psychiatrists are familiar with this intervention or its application to a range of patient behaviours. This paper describes contingency management and evidence of its efficacy for reducing drug use. It then details areas in which contingency management interventions can be applied in the context of psychiatric treatments more generally, including increasing abstinence in individuals with dual diagnoses, encouraging attendance in mental health treatment settings, enhancing adherence to psychiatric medications, reducing weight, and improving exercise. Greater awareness and use of contingency management in practice may improve outcomes across a range of mental health and related conditions.


Sign in / Sign up

Export Citation Format

Share Document